1. Magnetic resonance as imaging diagnostic tool in prostate cancer: New evidences-The EAU Section of Uro-Technology position.
- Author
-
Álvarez-Maestro M, Gómez Rivas J, Quesada Olarte J, Carrión DM, Trelles Guzman C, Ballesteros C, Quintana LM, Aguilera Bazán A, Martínez-Piñeiro L, Liatsikos E, and Barret E
- Subjects
- Europe, Forecasting, Humans, Male, Practice Guidelines as Topic, Societies, Medical, Urology, Magnetic Resonance Imaging, Prostatic Neoplasms diagnostic imaging
- Abstract
Prostate cancer (PCa) is the second leading cause of cancer-related mortality and the most frequently diagnosed male malignant disease among men. The manifestation of PCa ranges from indolent to highly aggressive disease and due to this high variation in PCa progression, the diagnosis and subsequent treatment planning can be challenging. The current diagnostic approach with PSA testing and digital rectal examination followed by transrectal ultrasound biopsies lack in both sensitivity and specificity in PCa detection and offers limited information about the aggressiveness and stage of the cancer. Scientific work supports the rapidly growing use of multiparametric magnetic resonance imaging as the most sensitive and specific imaging tool for detection, lesion characterization and staging of PCa. Therefore, we carried out an updated review of magnetic resonance imaging in the diagnostic PCa reviewing the latest papers published in PubMed., (Copyright © 2019 AEU. Publicado por Elsevier España, S.L.U. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF